China National Medicines Corporation Ltd.
600511
Rangering i aksjer
#4963
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Aksjekurs
$3.90
Markedsverdi
$2.94B
Endring (1 dag)
-1.46%
Endring (1 år)
-3.02%
Land
CN
Handel China National Medicines Corporation Ltd. (600511)
Kategori
Healthcare
Antall utestående aksjer for China National Medicines Corporation Ltd. (600511)
Antall utestående aksjer per June 2026: 722.47M
Ifølge China National Medicines Corporation Ltd. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 722.47M. Ved slutten av December 2023 hadde selskapet 754.50M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for China National Medicines Corporation Ltd. (600511) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 722.47M | -4.25% |
| 2024 | 754.51M | 0.00% |
| 2023 | 754.50M | 0.00% |
| 2022 | 754.50M | 0.00% |
| 2021 | 754.50M | 0.00% |
| 2020 | 754.50M | -0.98% |
| 2019 | 761.95M | -0.62% |
| 2018 | 766.72M | 4.14% |
| 2017 | 736.25M | 6.20% |
| 2016 | 693.26M | 44.79% |
| 2015 | 478.80M | 0.00% |
| 2014 | 478.82M | 0.01% |
| 2013 | 478.78M | 0.00% |
| 2012 | 478.78M | -0.01% |
| 2011 | 478.84M | 0.01% |
| 2010 | 478.79M | 0.01% |
| 2009 | 478.76M | -0.01% |
| 2008 | 478.82M | 0.00% |
| 2007 | 478.83M | 0.00% |
| 2006 | 478.82M | 0.00% |
| 2005 | 478.82M | 0.00% |
| 2004 | 478.82M | 0.00% |
| 2003 | 478.82M | 0.00% |
| 2002 | 478.82M | 0.00% |
| 2001 | 478.82M | 0.00% |
| 2000 | 478.82M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 118.70M | -83.57% |
US
|
|
| - | - |
US
|
|
| 236.00M | -67.33% |
US
|
|
| - | - |
US
|
|
| 11.50B | 1,492.14% |
AU
|
